Colgate-Palmolive (CL) is exploring the sale of some personal-care brands, and targets about USD 1bln from total sales, sources say

Consumer staples groups pruning low-growth personal-care labels is a well-worn playbook: the majors have repeatedly shed tail brands to large-cap private equity or trade buyers, with proceeds typically recycled into debt reduction, buybacks, or the core oral-care and pet franchises that carry the group's multiple. At roughly USD 1bln of targeted proceeds against CL's scale, this is portfolio tidying rather than strategic repositioning; episodes of this size have historically moved the shares modestly, with the bigger effect confined to the brands' direct peer set if a trade buyer emerges. The 'exploring, sources say' framing matters: at this stage the process is unconfirmed and can stall, and past exploratory stories in staples have often gone quiet before resurfacing as formal processes. The tells are whether a bank is formally mandated, whether the perimeter extends beyond personal care, and whether management comments on capital deployment at the next results or investor day. Watch also for read-across to peers carrying similar tail portfolios, since divestiture programmes in this space have tended to come in waves when one major starts. The FX tag is incidental; the transmission is equity and credit, not currencies.